Centrus Energy (LEU) has drawn fresh investor attention after securing significant federal funding and outlining a substantial expansion of its centrifuge manufacturing plant, reinforcing its role as the only licensed HALEU producer in the Western world.

The federal funding and HALEU expansion news come after a period where the share price has fallen 33% year to date to US$182.47, even as the 1 year total shareholder return is 43.77% and the 5 year total shareholder return is close to 7x.

If you want to see how other nuclear fuel and infrastructure stocks are trading around similar themes, this is a good moment to scan the 88 nuclear energy infrastructure stocks

So with Centrus delivering 3% annual revenue growth, a modest decline in net income growth, and trading at a 45% to 53% discount to both intrinsic and analyst estimates, is this a genuine mispricing or is the market already factoring in future growth?

Most Popular Narrative: 70.1% Undervalued

The most followed valuation narrative puts Centrus Energy's fair value at $609.90 per share, compared with the last close at $182.47, which is a wide gap for investors to weigh.

Centrus Energy is one of those rare companies whose importance becomes clearer the deeper you look into the machinery of U.S. law, national security, and nuclear policy. In a sector defined by scarcity, Centrus isn’t just another uranium company; it is the only U.S. company legally authorized to enrich uranium for the federal government, a distinction rooted directly in federal statute.

When the U.S. government says it needs domestically enriched uranium, it doesn’t have a menu of options. It has Centrus. Read the complete narrative.

Want to see how a single NRC license, HALEU focus, and projected revenue ramp feed into that valuation? The narrative leans heavily on growth, margins, and future multiples.

Result: Fair Value of $609.90 (UNDERVALUED)

However, this hinges on policy staying favorable and Centrus executing on HALEU expansion. Any regulatory shift or project setback could quickly weaken that thesis.

Another View: High P/E Puts the Brakes On

That $609.90 fair value from the narrative sits awkwardly beside the current P/E of 59.2x, which is far higher than the US Oil and Gas industry at 13.1x, the peer average at 11.4x, and the fair ratio of 10.9x. If sentiment cools, how much room is there for the multiple to compress?

See what the numbers say about this price in more detail with our valuation breakdown, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With mixed sentiment running through this story, you should move quickly, review the full picture, and weigh both sides by checking the 1 key reward and 4 important warning signs.

Looking for more investment ideas?

If Centrus has caught your attention, do not stop here; broaden your watchlist now so you are not relying on a single opportunity.

• Spot potential bargains early by scanning 46 high quality undervalued stocks that pair solid fundamentals with prices the market has not fully reflected yet.
• Strengthen your income focus by reviewing 10 dividend fortresses that aim to combine substantial yields with resilient business models.
• Sleep a little easier by checking 62 resilient stocks with low risk scores that score well on financial health and volatility, so surprises are less frequent.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.